Trial of syphilis pre-exposure prophylaxis opens to enrollment

The study team screened its first participant for the DaDHS trial of doxycycline as pre-exposure prophylaxis against syphilis and other bacterial sexually transmitted infections today.  Congratulations to study coordinator Reva Persaud for launching the trial!  Read more about the trial here.

Read more
Options Lab Postdoctoral Fellow Oscar Pico-Espinosa has two abstracts from the PRIMP study accepted to EACS

Oscar’s analyses on “PrEP-related stigma and PrEP status among gay, bisexual and other men who have sex with men, and transgender women in Ontario and British Columbia, Canada” and the PrEP cascade among HIV-negative gay, bisexual and other men who have sex with men (gbMSM) in Ontario and British Columbia” will be presented as posters […]

Read more
Options Lab MPH students Adrian Foster and Lauren Tailor invited to present at the Fast-Track Cities 2021 Conference

Adrian Foster will present his work on PrEP stigma and Lauren Tailor will present her work on mental health conditions in PrEP users at the upcoming Fast-Track Cities 2021 Conference in Lisbon, hosted by the International Association of Providers of AIDS Care (IAPAC). You can read more about the conference here.

Read more
Options Lab PDF Oscar Pico-Espinosa receives award

Oscar’s research on Reasons for declining PrEP, part of the PRIMP project, received a Trainee Award and will be presented at the major infectious diseases conference ID Week at the end of September 2021.  Congratulations Oscar!  See the conference webpage here.

Read more